Internal Medicine, Rheumatology · Monroe, LA
NPI
1184635344
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3402 Magnolia Cove
Monroe, LA, 71203
Phone (318) 388-5830
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.8M
412,482 services
Medicare patients, 2024
1,228
Average age 74
Drug cost, 2024
$10.4M
21,799 prescriptions
Company payments, 2025
$3,574
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jyothi R Mallepalli was code J3262 (injection, tocilizumab, 1 mg), 143,720 times for 27 patients. In total Jyothi R Mallepalli billed 412,482 services in 89 codes, and Medicare paid $3.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 143,720 | 27 | $4.72 | $679K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 119,600 | 40 | $3.61 | $432K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 40,400 | 55 | $9.15 | $370K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 28,770 | 21 | $8.54 | $246K |
| J0897 Injection, denosumab, 1 mg | Office | 20,280 | 207 | $20.38 | $413K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 6,050 | 12 | $33.89 | $205K |
| 36415 Venipuncture Blood Collection | Office | 3,574 | 1,147 | $8.59 | $31K |
| 99214 Office E&M - Established | Office | 3,569 | 1,101 | $85.39 | $305K |
| 80053 Clinical Chemistry | Office | 3,453 | 1,134 | $10.27 | $35K |
| 85025 Blood Count | Office | 3,411 | 1,129 | $7.55 | $26K |
| 86140 Clinical Chemistry | Office | 3,133 | 1,053 | $5.04 | $16K |
| 84550 Clinical Chemistry | Office | 3,105 | 1,052 | $4.40 | $14K |
| 85651 Clinical Chemistry | Office | 3,095 | 1,040 | $4.17 | $13K |
| 82550 Clinical Chemistry | Office | 3,087 | 1,052 | $6.35 | $20K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,750 | 235 | $0.71 | $1,244 |
By year: 2022 $3.5M for 410,468 services; 2023 $3.5M for 424,121 services; 2024 $3.8M for 412,482 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 3,574 | 1,147 | $8.59 | $31K |
| 80053 Clinical Chemistry | 3,453 | 1,134 | $10.27 | $35K |
| 85025 Blood Count | 3,411 | 1,129 | $7.55 | $26K |
| 86140 Clinical Chemistry | 3,133 | 1,053 | $5.04 | $16K |
| 84550 Clinical Chemistry | 3,105 | 1,052 | $4.40 | $14K |
| 85651 Clinical Chemistry | 3,095 | 1,040 | $4.17 | $13K |
| 82550 Clinical Chemistry | 3,087 | 1,052 | $6.35 | $20K |
| 86235 Immunoassay | 1,211 | 172 | $17.39 | $21K |
| 81003 Clinical Chemistry | 1,135 | 540 | $2.19 | $2,486 |
| 86160 Immunoassay | 698 | 252 | $11.64 | $8,126 |
Medicare prescription drug claims, 2024
In 2024, the drug Jyothi R Mallepalli prescribed most often to Medicare patients was Tramadol Hcl, with 2,111 prescriptions and refills. In total Jyothi R Mallepalli wrote 21,799 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl Generic | 2,111 | 2,137 | 450 | $13K |
| Methotrexate Methotrexate Sodium | 1,999 | 3,109 | 406 | $44K |
| Gabapentin Generic | 1,920 | 2,763 | 460 | $26K |
| Prednisone Generic | 1,564 | 2,173 | 458 | $6,652 |
| Hydroxychloroquine Sulfate Generic | 1,101 | 1,874 | 243 | $49K |
| Potassium Chloride Generic | 1,073 | 1,685 | 278 | $18K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,025 | 1,026 | 133 | $19K |
| Leflunomide Generic | 931 | 1,421 | 204 | $42K |
| Celecoxib Generic | 782 | 1,124 | 187 | $13K |
| Tizanidine Hcl Generic | 721 | 1,185 | 192 | $6,561 |
| Cyclobenzaprine Hcl Generic | 517 | 737 | 139 | $3,956 |
| Diclofenac Sodium Generic | 497 | 668 | 155 | $20K |
| Meloxicam Generic | 496 | 803 | 160 | $2,105 |
| Alendronate Sodium Generic | 495 | 876 | 142 | $3,559 |
| Humira(Cf) Pen Adalimumab | 350 | 361 | 41 | $2.6M |
Brand drugs: - claims; generic drugs: 19,607 claims; opioid claims: 3,197.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jyothi R Mallepalli $3,574 ($3,574 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $802.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 44 | $802 |
| Amgen Inc. AMGN | 42 | $762 |
| UCB, Inc. UCB.BR | 27 | $479 |
| Janssen Biotech, Inc. JNJ | 17 | $386 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $262 |
| GlaxoSmithKline, LLC. GSK | 14 | $226 |
| Mallinckrodt Hospital Products Inc. | 5 | $93.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92.63 |
| Genzyme Corporation SNY | 3 | $62.95 |
| United Therapeutics Corporation UTHR | 2 | $59.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.